drugset / Trial / NCT03160001

Niclosamide With Etanercept in Rheumatoid Arthritis

NCT03160001

Phase 1/2 Completed 110 enrolled Faiq Gorial
RandomizedParallel-groupDouble-blindOther

Summary

Assessment of the adjuvant use Niclosamide With Etanercept in Rheumatoid Arthritis

Timeline

Start
2017-08-15
Primary completion
2018-08-15
Completion
2018-12-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Niclosamide Unknown 500 mg Oral
Background Etanercept Protein / enzyme biologic 50 mg

Indications